Found 51 matching trials
Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR) PHASE2 Open-label phase II, single arm, multicenter study with safety run-in to ev...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy PHASE3 A study evaluating the effectiveness and safety of venetoclax, in combinati...
Show More Location
Arizona Oncology Associates, PC-HOPE /ID# 211509
Learn More & Join Trial
HMA-Venetoclax Induction in Newly Diagnosed AML PHASE2 Acute myeloid leukaemia (AML) is a clonal haematological malignancy charact...
Show More Location
National University of Medical Sciences, Clinical Trial Unit
Learn More & Join Trial
Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC) PHASE4 Open-label study to evaluate the safety and tolerability of Sorafenib dose ...
Show More Location
University of Florida Hepatology
Learn More & Join Trial
Effects of Trancutaneous Auriculotemporal Nerve Stimulation NA Neuromodulation works by either actively stimulating nerves, causing the al...
Show More Location
Universidad del Gran Rosario
Learn More & Join Trial
Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients PHASE1 The study is a multicenter, open label Phase I/II trial.
1. To determine t...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma PHASE2 This study will help researchers understand how effective the combination o...
Show More Status
Active Not Recruiting
Location
City of Hope Cancer Center (Data collection only)
Learn More & Join Trial
Acalabrutinib and Venetoclax Treatment of Newly Diagnosed Patients With CLL at High Risk of Infection or Early Treatment PHASE2 Many patients with CLL have a weakened immune system due to their disease. ...
Show More Learn More & Join Trial
Five-day 20-minute 10-Hz tACS in Patients With a Disorder of Consciousness NA This study first aims to validate the feasibility of a multimodal 5-day 20-...
Show More Location
Multiple Locations
Learn More & Join Trial
Nicotine Withdrawal Symptoms and Smoking Relapse NA Background:
\- Smoking is thought to cause changes in the brain that lead ...
Show More Location
National Institute on Drug Abuse
Learn More & Join Trial